BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 32798018)

  • 21. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
    Zhang J; Jiang H; Liu DH; Wang GN
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Troxerutin Protects Against Myocardial Ischemia/Reperfusion Injury Via Pi3k/Akt Pathway in Rats.
    Shu L; Zhang W; Huang C; Huang G; Su G
    Cell Physiol Biochem; 2017; 44(5):1939-1948. PubMed ID: 29241161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart protective effects and mechanism of quercetin preconditioning on anti-myocardial ischemia reperfusion (IR) injuries in rats.
    Liu H; Guo X; Chu Y; Lu S
    Gene; 2014 Jul; 545(1):149-55. PubMed ID: 24769323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxysafflor yellow A cardioprotection in ischemia-reperfusion (I/R) injury mainly via Akt/hexokinase II independent of ERK/GSK-3β pathway.
    Min J; Wei C
    Biomed Pharmacother; 2017 Mar; 87():419-426. PubMed ID: 28068632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
    Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
    Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influences of remifentanil on myocardial ischemia-reperfusion injury and the expressions of Bax and Bcl-2 in rats.
    Li J; Hu HP; Li Y; Shao W; Zhang JZ; Wang LM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8951-8960. PubMed ID: 30575939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-Lipoic acid reduces infarct size and preserves cardiac function in rat myocardial ischemia/reperfusion injury through activation of PI3K/Akt/Nrf2 pathway.
    Deng C; Sun Z; Tong G; Yi W; Ma L; Zhao B; Cheng L; Zhang J; Cao F; Yi D
    PLoS One; 2013; 8(3):e58371. PubMed ID: 23505496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway.
    Li Q; Shen L; Wang Z; Jiang HP; Liu LX
    Biomed Pharmacother; 2016 Dec; 84():106-114. PubMed ID: 27643552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotection induced by sevoflurane-delayed post-conditioning is attributable to increased phosphorylation of mitochondrial GSK-3β through the PI3K/Akt survival pathway.
    Ye Z; Xia P; Cheng ZG; Guo Q
    J Neurol Sci; 2015 Jan; 348(1-2):216-25. PubMed ID: 25555490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
    Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
    J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Icariside II ameliorates myocardial ischemia and reperfusion injury by attenuating inflammation and apoptosis through the regulation of the PI3K/AKT signaling pathway.
    Guan BF; Dai XF; Huang QB; Zhao D; Shi JL; Chen C; Zhu Y; Ai F
    Mol Med Rep; 2020 Oct; 22(4):3151-3160. PubMed ID: 32945440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nerve growth factor protects the ischemic heart via attenuation of the endoplasmic reticulum stress induced apoptosis by activation of phosphatidylinositol 3-kinase.
    Wei K; Liu L; Xie F; Hao X; Luo J; Min S
    Int J Med Sci; 2015; 12(1):83-91. PubMed ID: 25552923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
    Chang JH; Jin MM; Liu JT
    Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of miR-26a targeting GSK-3β/β-catenin signaling pathway on myocardial apoptosis in rats with myocardial ischemia-reperfusion.
    Gong DD; Yu J; Yu JC; Jiang XD
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):7073-7082. PubMed ID: 31486509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigallocatechin gallate exerts protective effects against myocardial ischemia/reperfusion injury through the PI3K/Akt pathway-mediated inhibition of apoptosis and the restoration of the autophagic flux.
    Xuan F; Jian J
    Int J Mol Med; 2016 Jul; 38(1):328-36. PubMed ID: 27246989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-Term Hesperidin Pretreatment Attenuates Rat Myocardial Ischemia/Reperfusion Injury by Inhibiting High Mobility Group Box 1 Protein Expression via the PI3K/Akt Pathway.
    Li X; Hu X; Wang J; Xu W; Yi C; Ma R; Jiang H
    Cell Physiol Biochem; 2016; 39(5):1850-1862. PubMed ID: 27744432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sphingosine 1-Phosphate Postconditioning Protects Against Myocardial Ischemia/reperfusion Injury in Rats via Mitochondrial Signaling and Akt-Gsk3β Phosphorylation.
    Fang R; Zhang LL; Zhang LZ; Li W; Li M; Wen K
    Arch Med Res; 2017 Feb; 48(2):147-155. PubMed ID: 28625317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
    Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
    Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urolithin A alleviates myocardial ischemia/reperfusion injury via PI3K/Akt pathway.
    Tang L; Mo Y; Li Y; Zhong Y; He S; Zhang Y; Tang Y; Fu S; Wang X; Chen A
    Biochem Biophys Res Commun; 2017 May; 486(3):774-780. PubMed ID: 28343995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK.
    Jeong CW; Yoo KY; Lee SH; Jeong HJ; Lee CS; Kim SJ
    J Cardiovasc Pharmacol Ther; 2012 Dec; 17(4):387-94. PubMed ID: 22396328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.